Skip to main content
. 2020 Jul 3;21(13):4753. doi: 10.3390/ijms21134753

Table 2.

Significantly changed lipid compounds that decreased or increased between PCOS and control (plasma samples). Discovery determined using the two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 5%. Each row was analysed individually, without assuming a consistent SD. * Metabolite identification confidence score as described elsewhere [12].

Name Identity Confidence Score * m/z Retention Time (min) Increase (↑) or Decrease (↓) Fold Change t-Test (p) Q-Value
Heptadecanoic acid (17:1) 2 267.232 1.70 0.59 5.27 × 10−6 7.84 × 10−3
Palmitoleic acid (16:1) 2 253.217 1.52 0.57 5.60 × 10−6 7.84 × 10−3
Pentadecenoic acid (15:1) 2 239.201 1.35 0.65 4.76 × 10−5 2.16 × 10−2
Palmitic acid (16:0) 2 255.233 1.81 0.74 6.30 × 10−5 7.84 × 10−3
Heptadecanoic acid (17:0) 2 269.248 2.03 0.78 1.07 × 10−4 3.21 × 10−2
Myristic acid (14:0) 2 227.201 1.40 0.65 1.41 × 10−4 3.95 × 10−2
Docosatrienoic acid (22:3) 2 333.279 2.11 0.64 1.71 × 10−4 4.45 × 10−2
Eicosadienoic acid (20:2) 2 307.264 1.99 0.70 3.79 × 10−3 2.16 × 10−2
Steroid (dihydrotestosterone or isomer) sulphate 4 369.172 0.45 2.79 1.00 ×10−5 9.64 × 10−3
Hexacosahexaenoic acid (26:6) 2 383.297 2.05 1.23 5.13 × 10−5 2.23 × 10−2
Steroid (testosterone or isomer) sulphate 4 367.158 0.43 2.23 5.20 × 10−5 2.23 × 10−2